✦ LIBER ✦

Ovarian cancer: Age contrasts in incidence, histology, disease stage at diagnosis, and mortality

✍ Scribed by Rosemary Yancik

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 685 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.2820710205

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hereditary ovarian cancer. Heterogeneity

Hereditary ovarian cancer. Heterogeneity in age at diagnosis

✍ Henry T. Lynch; Patrice Watson; Chhanda Bewtra; Theresa A. Conway; Connie Read H 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 684 KB

Borderline ovarian tumors in Sweden 1960

Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancer

✍ Ingiridur Skírnisdóttir; Hans Garmo; Erik Wilander; Lars Holmberg 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 179 KB

## Abstract The aim of the study was to investigate long‐term trends in the incidence of borderline tumors and ovarian cancer in Sweden during 1960–2005, based on data from the population‐based Swedish Cancer Register. We identified 6,288 patients with borderline ovarian tumors and a total of 34,97

Stage at diagnosis of ovarian cancer in

Stage at diagnosis of ovarian cancer in the United States, 1992–1997

✍ Marc T. Goodman; Catherine N. Correa; Ko-Hui Tung; Steven D. Roffers; Xiao Cheng 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 1 views

R%: relative percentage. a Malignant ovarian tumors exclude serous cystadenoma (8442), papillary cystadenoma (8451), papillary serous cystadenoma (8462), mucinous cystadenoma (8472), and papillary mucinous cystadenoma (8473). b Rates are per 100,000 and are age-adjusted to the 1970 United States sta

Secular changes in colorectal cancer inc

Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992–2001

✍ Rosemary D. Cress; Cyllene Morris; Gary L. Ellison; Marc T. Goodman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 1 views

Dynamic contrast-enhanced MRI in ovarian

Dynamic contrast-enhanced MRI in ovarian cancer: Initial experience at 3 tesla in primary and metastatic disease

✍ Andrew N. Priest; Andrew B. Gill; Masako Kataoka; Mary A. McLean; Ilse Joubert; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

The aim of this study was to develop and demonstrate a methodology for dynamic contrast-enhanced MRI at 3 T in patients with advanced ovarian cancer and to report the results from pharmacokinetic modeling of the data. Nineteen patients with suspected advanced ovarian carcinoma (FIGO stage 3 or highe

Cancer incidence rate and mortality rate

Cancer incidence rate and mortality rate in sickle cell disease patients at Howard University Hospital: 1986-1995

✍ Dawkins, Fitzroy W.; Kim, Kyung Sook; Squires, Richard S.; Chisholm, Reginald; K 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

The incidence of cancer in patients with sickle cell disease (SCD) is not known. The 10-year follow-up data on 696 patients with SCD was analyzed at our institution in order to determine the cancer incidence and cancer mortality rates. The age range was 18 to 79 years, with a mean age of 28.8 years.